Centessa Pharmaceuticals GAAP EPS of -$0.20 beats by $0.15, revenue of $15M

1 month ago 4

Centessa Pharmaceuticals press release (NASDAQ:CNTA): Q1 GAAP EPS of -$0.20 beats by $0.15.
Revenue of $15M.
Cash, cash equivalents and investments totaled $424.9 million as of March 31, 2025. The Company expects its cash, cash equivalents and investments as of March 31, 2025 will fund operations into mid-2027.

Recommended For You